Key facts
- This page summarizes Donald Allen Williams's Form 4 filing for PALISADE BIO, INC. (PALI).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Sep 2025, 09:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.
Footnote F2
The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date
Footnote F3
Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.